BIO 2012 Spotlight: Discussions On Biosimilars, EMs, Partnerships And Global R&D
This article was originally published in PharmAsia News
During BIO 2012 in Boston last week global pharma leaders discussed many topics related to emerging markets. PharmAsia News takes a closer look.
You may also be interested in...
With collaborative research agreement templates that include many of the details for a licensing agreement, royalties will be the major issue to be resolved if researchers develop new IP for one of the firm’s abandoned compounds.
Pre-Competitive Collaboration Would Help Pharmaceutical Productivity Crisis - If Lawyers Could Get Out Of The Way
CAMBRIDGE, Mass. - Greater R&D collaboration was the theme of the day at the star-studded U.S.-India Chamber of Commerce biopharma and healthcare summit
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.